Product NDC: | 0054-8858 |
Proprietary Name: | Triazolam |
Non Proprietary Name: | Triazolam |
Active Ingredient(s): | .125 mg/1 & nbsp; Triazolam |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0054-8858 |
Labeler Name: | Roxane Laboratories, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA074224 |
Marketing Category: | ANDA |
Start Marketing Date: | 19940601 |
Package NDC: | 0054-8858-25 |
Package Description: | 10 TABLET in 1 BLISTER PACK (0054-8858-25) |
NDC Code | 0054-8858-25 |
Proprietary Name | Triazolam |
Package Description | 10 TABLET in 1 BLISTER PACK (0054-8858-25) |
Product NDC | 0054-8858 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Triazolam |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 19940601 |
Marketing Category Name | ANDA |
Labeler Name | Roxane Laboratories, Inc. |
Substance Name | TRIAZOLAM |
Strength Number | .125 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Benzodiazepine [EPC],Benzodiazepines [Chemical/Ingredient] |